Company Description
Ridgetech, Inc. operates as a wholesale distributor of pharmaceutical and other healthcare products in the People’s Republic of China.
It operates through three segments: Retail Drugstores, Online Pharmacy, and Drug Wholesale. The company engages in offline and online wholesale distribution of pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products comprising consumable, seasonal, and promotional items.
It also distributes other healthcare products, such as health food, cosmetics, and daily necessities.
The company was formerly known as China Jo-Jo Drugstores, Inc. and changed its name to Ridgetech, Inc. in February 2024.
Ridgetech, Inc. is headquartered in Hangzhou, China.
| Country | China |
| Industry | Pharmaceutical Retailers |
| Sector | Healthcare |
| Employees | 61 |
| CEO | Ming Zhao |
Contact Details
Address: Building 5, 4th Floor Hangzhou, 310008 China | |
| Phone | 86 57 1882 19579 |
| Website | ridgetch.com |
Stock Details
| Ticker Symbol | RDGT |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001856084 |
| ISIN Number | KYG2124G1203 |
Key Executives
| Name | Position |
|---|---|
| Ming Zhao | Interim Chief Executive Officer and Chief Financial Officer |
| Steve Liu | Investor Relations Director |
| Yan Liu | Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 28, 2025 | 20-F | Annual and transition report of foreign private issuers |
| Jul 28, 2025 | 6-K | Report of foreign issuer |
| Jun 4, 2025 | 6-K | Report of foreign issuer |
| Mar 6, 2025 | SCHEDULE 13D | Filing |
| Mar 4, 2025 | SCHEDULE 13D/A | Filing |
| Mar 3, 2025 | 6-K | Report of foreign issuer |
| Feb 5, 2025 | 6-K | Report of foreign issuer |
| Feb 3, 2025 | 6-K | Report of foreign issuer |
| Jan 15, 2025 | 6-K | Report of foreign issuer |
| Nov 14, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |